跳至主要内容
临床试验/CTRI/2023/08/056956
CTRI/2023/08/056956尚未招募3 期

PULMONARY REHABILITATION TO REDUCE POST-TUBERCULOSIS MORBIDITY (TB PURE)-A RANDOMISED MULTI-CENTRE TRIAL

US National Institutes of Health2 个研究点 分布在 1 个国家目标入组 690 人开始时间: 2023年1月9日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
690
试验地点
2
主要终点
6MWT

研究概览

简要总结

Title:

Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB PuRe)

|Population:

690 adults with drug-sensitive pulmonary tuberculosis (TB) with impaired functional status at study enrollment

|Intervention:

8 weeks (short arm) or 24 weeks (extended arm) of a pulmonary rehabilitation (PR) program, administered during TB treatment, comprising of exercise training, counselling and education, and airway clearance techniques

|Objectives**:**

1.       To compare the effectiveness of two home-based PR programs, administered during TB treatment, for preventing post-TB respiratory morbidity.

2.       To describe the intersection between clinic-level service organization, fidelity of intervention delivery, and change in client behavior for the two PR programs.

3.       To compare the costs, cost-effectiveness, and budget impact of the two different PR strategies implemented as a routine program.

|Design/Methodology:

Individual-level, unblinded randomized controlled trial of an 8-week (short arm) or 24-week (extended arm) pulmonary rehabilitation program, relative to standard of care, to prevent post-tuberculosis respiratory morbidity. Randomization will occur in a 1:1:1 ratio at the initiation of treatment.

|Primary Outcome:

Mean 6-minute walk test distance compared between the three study arms at 48 weeks after enrollment

|Total Study Duration:

5 years

|Subject Participation Duration:

48 weeks

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, fixed
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Microbiologically confirmed (smear microscopy, GeneXpert or culture) pulmonary TB disease.Participants with just smear microscopy results will be enrolled provisionally to stay within the window of enrollment.
  • Thereafter, if the culture results indicate drug resistance, the participant will be offered the opportunity to participate in follow-up visits, can continue with the intervention, but the data will not be considered in the final analysis.
  • Not completed more than 2 weeks of TB treatment Receiving TB care at the outpatient clinics at the TB PuRe study sites Willingness to complete 48 weeks of study evaluations.
  • Access to a smartphone.

排除标准

  • Modified Medical Research Council score of 0 points (dyspnea only with strenuous exercise) Multi or extensively drug-resistant TB disease.
  • Extrapulmonary TB disease at any clinical sites without pulmonary involvement TB meningitis or TB of the spine Symptomatic cardiovascular disease, including coronary artery disease, arrhythmias and congestive cardiac failure.
  • Karnofsky Score < 40 points Any medical condition that prevents pulmonary rehabilitation eg: fracture of lower/upper limbs/pregnancy Bronchodilators and/or corticosteroids inhaled or otherwise.

结局指标

主要结局

6MWT

时间窗: Mean distance compared between study arms at 48 weeks after enrollment

Population:

时间窗: 690 adults with drug-sensitive pulmonary tuberculosis (TB) with impaired functional status at study enrollment

Intervention:

时间窗: 8 weeks (short arm) or 24 weeks (extended arm) of a pulmonary rehabilitation (PR) program, administered during TB treatment, comprising of exercise training, counselling and education, and airway clearance techniques

Objectives :

时间窗: 1.        To compare the effectiveness of two home-based PR programs, administered during TB treatment, for preventing post-TB respiratory morbidity. 2.        To describe the intersection between clinic-level service organization, fidelity of intervention delivery, and change in client behavior for the two PR programs. 3.        To compare the costs, cost-effectiveness, and budget impact of the two different PR strategies implemented as a routine program.

Design/Methodology:

时间窗: Individual-level, unblinded randomized controlled trial of an 8-week (short arm) or 24-week (extended arm) pulmonary rehabilitation program, relative to standard of care, to prevent post-tuberculosis respiratory morbidity. Randomization will occur in a 1:1:1 ratio at the initiation of treatment.

Primary Outcome:

时间窗: Mean 6-minute walk test distance compared between the three study arms at 48 weeks after enrollment

Total Study Duration:

时间窗: 5 years

Subject Participation Duration:

时间窗: 48 weeks

次要结局

  • 6 Minute walk test(Mean 6MWT distance compared between study arms at 8 16 and 24 weeks after enrollment)
  • SGRQ mMRC CRQ CAT scores(Total and sub-domain questionnaire scores compared between study arms at 8 16 24 48 weeks after enrollment)
  • Lung function(FEV1 and FVC)

研究者

发起方
US National Institutes of Health
申办方类型
Government funding agency

研究点 (2)

Loading locations...

相似试验

A clinical trial of pulmonary rehabilitation to... | 临床试验